U.S. market Closed. Opens in 1 day 10 minutes

RXDX | Prometheus Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312016-12-312015-12-312014-12-31
Revenue6.81M3.13M1.23M1.12MN/AN/A150.00K
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross Profit6.81M3.13M1.23M1.12MN/AN/A150.00K
Operating Expenses152.59M90.93M30.24M17.09M100.68M90.58M40.00M
Selling, General & Admin39.74M28.50M11.09M6.13M23.76M17.07M9.49M
Research & Development112.85M62.43M19.15M10.96M76.93M73.51M30.51M
Other Operating Expenses4.03M-2.39M-15.00KN/AN/AN/AN/A
Operating Income-145.78M-87.80M-29.01M-15.97M-100.68M-90.58M-39.85M
Other Expenses / Income4.03M-2.39M-2.13M-761.00K-2.96M-1.88M-128.42K
Before Tax Income-141.75M-90.19M-31.14M-16.73M-103.64M-92.46M-39.98M
Income Tax Expenses-629.00K-258.00K8.11M13.76M259.00KN/A12.33K
Net Income-141.75M-89.94M-39.25M-30.49M-103.64M-92.46M-39.99M
Interest ExpensesN/A861.00K2.13M770.00K3.21M2.59MN/A
Basic Shares Outstanding40.62M31.33M34.61M26.98M38.48M26.85M18.33M
Diluted Shares Outstanding40.62M31.33M34.61M26.98M38.48M26.85M18.33M
EBITDA-145.78M-87.80M-28.90M-15.92M-96.95M-87.83M-39.45M
EBITDA Margin-2,140.96%-2,806.10%-2,351.51%-1,424.33%0.00%0.00%-26,299.76%
EBIT-142.38M-89.33M-29.01M-15.96M-100.17M-89.86M-39.98M
EBIT Margin-2,091.07%-2,855.03%-2,360.37%-1,427.46%0.00%0.00%-26,651.54%
Financial Year End2022-12-312021-12-312020-12-312019-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙